$9.41+0.58 (+6.57%)
Ardent Health, Inc.
Ardent Health, Inc. in the Healthcare sector is trading at $9.41 with a market capitalization of $1.1B. Wall Street consensus targets $12.50 (11 analysts), implying a +32.8% move over the next 12 months. The stock is currently 39% below its 52-week high of $15.48, remaining 10.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, or...
Ardent Health has appointed former Chief Operating Officer Dave Caspers as President and Chief Executive Officer, and to its board, succeeding Marty Bonick following the company’s post-IPO transformation. This leadership shift places a seasoned operator of large-scale, tech-enabled healthcare systems at the helm, with direct oversight of Ardent’s IMPACT margin and care transformation program. We’ll now examine how Caspers’ elevation from COO to CEO could influence Ardent Health’s investment...
Leadership change and what it signals for Ardent Health stock Ardent Health (ARDT) has moved into the spotlight after appointing former Chief Operating Officer Dave Caspers as President, Chief Executive Officer, and board member, succeeding long time leader Marty Bonick. The board is tying this leadership shift to Ardent’s existing operating and growth plans, with Caspers continuing to oversee the IMPACT program, which targets margins, performance, agility, and care transformation across the...
Investing.com -- Bank of America upgraded UnitedHealth Group to Buy from Neutral and raised its price target to $450 from $420 per share in a note on Thursday, citing improving medical cost trends and a favorable setup heading into second-quarter earnings, analyst Kevin Fischbeck said.
Ardent elevated its former COO, Dave Caspers, to the top job as the Tennessee-based system grapples with its declining stock price.
Ardent Health, Inc. ( NYSE:ARDT ) last week reported its latest quarterly results, which makes it a good time for...